EconomyLiquidia shares plunge after US court rules for United Therapeutics in patent case
Liquidia shares fell nearly 50% on Wednesday after a federal judge ruled that its lung drug infringes a key patent held by rival United Therapeutics, dealing a major setback to the treatment’s commercial prospects.
R
Reuters★★☆☆☆2026-09-30 20:50Original
Liquidia shares plunge after US court rules for United Therapeutics in patent case
Economy